WATS: TMJ Fibrocartilage Detection Using MRI

Sponsor
Universidad de los Andes, Chile (Other)
Overall Status
Unknown status
CT.gov ID
NCT03891511
Collaborator
Universidad Mayor (Other), University of Chile (Other)
59
1
2.4
24.6

Study Details

Study Description

Brief Summary

Objective: The aims of this study will be to detect the fibrocartilage layer (FC) of the human temporomandibular joint (TMJ) using 3D SPGR (Spoiled GRASS sequence) (T1 WATS) sequence and to compare these results with those of conventional magnetic resonance imaging (DP, T2 MRI) sequences in patients with temporomandibular disorders (TMD).

Condition or Disease Intervention/Treatment Phase
  • Device: MRI scann

Detailed Description

This prospective and observational study will focused on analyzing morphological characteristics of the fibrocartilage layer of the TMJ based on the MRI scans of 59 patients. All 118 TMJs of these patients will be suitable for analysis, (range: 18-60 years old), females and males affected by TMD and did not undergo previous TMJ treatment.

Study Design

Study Type:
Observational
Anticipated Enrollment :
59 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
TMJ Fibrocartilage Detection Using 3D Fat-Suppressed Spoiled Gradient-Echo Magnetic Resonance Imaging
Actual Study Start Date :
Mar 18, 2019
Anticipated Primary Completion Date :
Apr 30, 2019
Anticipated Study Completion Date :
May 30, 2019

Outcome Measures

Primary Outcome Measures

  1. Presence of the TMJ Fibrocartilage layer [six months]

    The fibrocartilage layer will be evaluated dichotomously (absent/present) Patients will be examined using bilateral MRI (Phillips Intera 1,5 T, Sense Flex S Dual Coil) in the sagittal PD-weighted, T2-weighted and T1-weighted WATS, all in the oblique axis of the mandible condyle and with a closed mouth; dynamic gradient-echo at open mouth at 10 mm, 20 mm and 30 mm of the interincisal distance. Additionally, a coronal PD-weighted sequence with the mouth closed will be performed. Of each TMJ will be taken with 8×8 cm FOV and 0.2 cm spacing. All sequences will carried out using the same equipment and on the same day.

  2. Discontinuity of the TMJ FC layer [six months]

    The TMJ fibrocartilage layer will be evaluated dichotomously (continuous/discontinuous).

  3. Fibrocartilage Signal Intensity [six month]

    Six regions of interest (ROIs) will be measured in the fibrocartilage layer of each TMJ. (anterior 0°, center 45° and posterior 90°), three in the mandibular condyle and three in the temporal fossa. The fibrocartilage signal intensity in each ROI will be expressed as the mean value of intensity units (Osirix). All measurements will be made in a simple blinded system by four different observers (ML, MN, CV, GZ) (chi-square test for interobserver agreement: p˂0.05). Measurements will be made separately in the three MRI sequences (length tool, Osirix Imaging software). In all MRI sequences, TMJ will be magnified at a zoom of 3.6. For the T1 WATS sequence, the window width will be set at 90 intensity Units (IU) (all values above +90 Hounsfield Unit (HU) will be white), and the window level was 80 (IU) (all values below +80 HU will be black). All images will be measured and stored in DICOM format., lengt

  4. Thickness of the TMJ fibrocartilage layer [Six months]

    The TMJ FC thickness will be measured (curve tool, Osirix) and will expressed in millimeters.

  5. Length of the TMJ fibrocartilage layer [Six moths]

    The lenght of the TMJ FC layer will be measured (curve tool, Osirix) and will expressed in millimeters.

  6. Statistical analysis [seven months]

    The Shapiro-Wilk test and Levene's test will be performed to assess normality of data distribution and homogeneity of variance of the measurements, respectively. To determine the relationship between the presence or absence of fibrocartilage and the different sequences, Fisher's exact test will be used. The thickness, length and signal intensity of the fibrocartilage layer will be expressed as a mean value, separated by MRI sequence, and will be analyzed using descriptive statistics. SPSS v14.0 for Windows, statistical software will be used to perform data analysis.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Internal derangement in theTMJ
Exclusion Criteria:
  • Cardiac pacemaker

  • Cochlear implant

  • Intracranial vascular clips

  • Metal particles in the orbit

  • Head or face trauma

  • Gout

  • Generalized osteoarthrosis

  • Joint hyperlaxity

  • Congenital malformity

  • Facial cysts

  • Facial tumors

  • Previous TMJ surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 San Vicente de Paul Centro de Diagnóstico Santiago Chile 750005

Sponsors and Collaborators

  • Universidad de los Andes, Chile
  • Universidad Mayor
  • University of Chile

Investigators

  • Principal Investigator: Gustavo Moncada, PhD, UAndes, Santiago, Chile

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Gustavo Moncada, Principal investigator, Clinical Professor of Oral Rehabilitation, Universidad de los Andes, Chile
ClinicalTrials.gov Identifier:
NCT03891511
Other Study ID Numbers:
  • UM20-08-2
First Posted:
Mar 27, 2019
Last Update Posted:
Mar 27, 2019
Last Verified:
Mar 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 27, 2019